Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Neos Therapeutics (NEOS)

10.2 0.25 (2.51%)

12-13 16:00

Open:

9.95

Pre. Close:

9.95

High:

10.5

Low:

9.95

Volume:

651,288

Market Cap:

296M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

10.78 - 10.92

10.92 - 11.13

Low:

9.19 - 9.39

9.39 - 9.7

Close:

9.59 - 10.04

10.04 - 10.72

Technical analysis  (as of: 2017-12-13 5:05:46 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 13.02     One year: 15.21

Support:

Support1: 9.73    Support2: 8.85

Resistance:

Resistance1: 11.15    Resistance2: 13.02

Pivot:

9.82

Moving Averages:

MA(5): 9.87     MA(20): 9.91

MA(100): 8.70     MA(250): 7.60

MACD:

MACD(12,26): 0.03     Signal(12,26,9): 0.04

%K %D:

%K(14,3): 67.62     %D(3): 59.75

RSI:

RSI(14): 55.00

52-Week:

High: 13.15  Low: 4.85  Change(%): 50.0

Average Vol(K):

3-Month: 71837  10-Days 44160

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NEOS has closed below upper band by 22.5%. Bollinger Bands are 32% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 08 Nov 2017 11:01:08 GMT
Why Neos Therapeutics Inc Rose 13.7% In October

Thu, 26 Oct 2017 14:34:38 GMT
Neos Therapeutics' stock rockets after buyout bid, says it will respond in ...

Tue, 07 Nov 2017 12:56:15 GMT
Neos Therapeutics to Present at the Stifel 2017 Healthcare Conference

Wed, 30 Aug 2017 11:26:15 GMT
Neos Therapeutics to Participate in Three September Conferences

Fri, 11 Aug 2017 17:37:30 GMT
Neos Therapeutics' (NEOS) CEO Vipin Garg on Q2 2017 Results - Earnings Call ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

29.00

Shares Float (M)

20.10

% Held by Insiders

15.10

% Held by Institutions

55.61

Shares Short (K)

2320

Shares Short Prior Month (K)

2560

Stock Financials

EPS

-3.260

EPS Est. Current Year

-3.110

EPS Est. Next Year

-1.440

EPS Est. Next Quarter

-0.670

Forward EPS

-1.549

Book Value (p.s.)

0.520

PEG Ratio

-0.05

Profit Margin

Operating Margin

-299.77

Return on Assets (ttm)

-36.9

Return on Equity (ttm)

-460.1

Qtrly Rev. Growth

322.9

Gross Profit (p.s.)

-0.079

Sales Per Share

EBITDA (p.s.)

-2.070

Qtrly Earnings Growth

Operating Cash Flow (M)

-58.21

Levered Free Cash Flow (M)

-37.86

atoplab.com

Valuation

P/E

-3.13

P/E Growth Ratio

0.03

P/BV

19.62

P/S

308124992.00

P/CF

-5.08

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.